Global Blood Therapeutics, Inc.
GBTNASDAQHealthcare
$68.49
+$0.01(+0.01%)
Market Cap$0
P/E Ratio—
52W High$73.02
52W Low$21.65
Global Blood Therapeutics, Inc.（GBT）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · GBT · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2021-12 | 2020-12 | 2019-12 | 2018-12 | 2017-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.19B | $0.12B | $0.00B | $0.00B | $0.00B |
| Cost of Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Profit | $0.19B | $0.12B | $0.00B | $0.00B | $0.00B |
| Gross Margin %(computed) | 98.30% | 98.40% | 97.72% | — | — |
| Operating Expenses | |||||
| R&D Expenses | $0.21B | $0.16B | $0.17B | $0.13B | $0.09B |
| G&A Expenses | $0.00B | $0.00B | $0.12B | $0.05B | $0.03B |
| Total Operating Expenses | $0.48B | $0.37B | $0.29B | $0.18B | $0.12B |
| Operating Income | ($0.29B) | ($0.24B) | ($0.28B) | ($0.18B) | ($0.12B) |
| Operating Margin %(computed) | -147.44% | -196.42% | — | — | — |
| Interest Income | $0.00B | $0.01B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.02B | $0.01B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.30B) | ($0.25B) | ($0.27B) | ($0.17B) | ($0.12B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | ($0.30B) | ($0.25B) | ($0.27B) | ($0.17B) | ($0.12B) |
| Net Margin %(computed) | -155.63% | -199.96% | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-4.82 | $-4.04 | $-4.57 | $-3.41 | $-2.76 |
| Wtd Avg Shares | 0.06B | 0.06B | 0.06B | 0.05B | 0.04B |
| EBITDA | ($0.28B) | ($0.23B) | ($0.26B) | ($0.17B) | ($0.12B) |
| EBITDA Margin %(computed) | -143.02% | -183.29% | — | — | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · USD · B
深入了解Global Blood Therapeutics, Inc.
关于Global Blood Therapeutics, Inc.（GBT）损益表
Global Blood Therapeutics, Inc.（GBT）损益表数据来源于SEC Form 10-K及10-Q申报文件。2021财年，GBT实现营收$0.19B，毛利润$0.19B（毛利率98.30%），净利润($0.30B)（净利率-155.63%）。
常见问题
GBT · 4 问Global Blood Therapeutics, Inc.（GBT）2021财年营收为$0.19B，同比up57.3%。
GBT revenueGBT salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09